Bicycle Therapeutics

BCYC · NASDAQ

$3.60+$0.065 (+1.84%)TodayMarket closed ·
Prev close $3.54

Who owns BCYC

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 40.9% of BCYC’s shares.

  • Baker Bros. Advisors LP15.6%
  • Forbion Capital Partners5.0%
  • Armistice Capital LLC4.9%
  • Long Focus Capital Management LLC4.7%
  • Next 6 largest institutions10.8%
  • All other shareholders59.1%
Top institutional holders of BCYC
HolderShares% of shares
Baker Bros. Advisors LP10.89M15.59%
Forbion Capital Partners3.47M4.97%
Armistice Capital LLC3.40M4.87%
Long Focus Capital Management LLC3.31M4.74%
Acadian Asset Management LLC1.97M2.82%
Renaissance Technologies LLC1.53M2.20%
GSK plc1.53M2.19%
T. Rowe Price Associates, Inc.902.15K1.29%
Marshall Wace LLP797.94K1.14%
Qube Research & Technologies Ltd775.57K1.11%

Largest mutual fund holders

Top mutual fund holders of BCYC
HolderShares% of shares
T. Rowe Price Health Sciences Fund628.42K0.90%
iShares Biotechnology ETF276.69K0.40%
Old Westbury Small & Mid Cap Strategies Fund265.97K0.38%
Goldman Sachs Multi-Manager US Sm Cp Eqty99.18K0.14%
Virtus Biotech Clinical Trials ETF77.44K0.11%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $124.50K (25 trades) of BCYC on the open market, with no buys.

Latest BCYC insider transactions
InsiderTypeSharesValue
Perry Jennifer ScottSale326$1.23K
Perry Jennifer ScottSale30$107
Perry Jennifer ScottSale326$1.23K
Perry Jennifer ScottSale80$285
Hannay Michael Charles FergusonSale242$864
Thompson Travis AlvinSale79$282
Lee KevinSale1.64K$5.85K
Skynner MichaelSale503$1.80K
Perry Jennifer ScottSale1.09K$3.80K
Swanton Robert CharlesSale3.43K$11.91K

Short interest

Settled Sep 30, 2026

Shares short
3.30M
Days to cover
8.72
% of shares outstanding
4.73%
Average daily volume
378.57K
Change since last report
−0.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.